NBIX
NBIX
US64125C1099
Neurocrine Biosciences, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
14.48B EUR
17.12B EUR
13.25B EUR
14.2B EUR
Enterprise Value
14.43B EUR
17.19B EUR
13.39B EUR
13.9B EUR
Valuation Multiples
Trailing P/E
20.89x
24.27x
19.82x
30.16x
Forward P/E
11.99x
--
--
--
Price to Sales
4.29x
5.08x
4.27x
6.21x
Price to Book
3.92x
4.64x
3.89x
4.36x
EV/Revenue
4.28x
5.1x
4.32x
6.08x
EV/EBITDA
15.8x
20.99x
16.86x
21.01x
Price to FCF (P/FCF)
22.69x
19.67x
15.94x
20.44x
EV/FCF
22.61x
19.75x
16.11x
20.01x
FCF Yield
4.41%
5.08%
6.27%
4.89%
ende